DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Metaxalone is a drug marketed by Actavis Labs Fl Inc, Amneal Pharms, Ingenus Pharms Llc, Lannett Co Inc, Mountain, Primus Pharms, Rising, Sandoz, and Sciegen Pharms Inc. and is included in nine NDAs.
The generic ingredient in METAXALONE is metaxalone. There are twenty drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the metaxalone profile page.
A generic version of METAXALONE was approved as metaxalone by SANDOZ on March 31st, 2010.
Summary for METAXALONE
|Finished Product Suppliers / Packagers:||30|
|Raw Ingredient (Bulk) Api Vendors:||104|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for METAXALONE|
|Drug Sales Revenues:||Drug sales revenues for METAXALONE|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for METAXALONE|
|What excipients (inactive ingredients) are in METAXALONE?||METAXALONE excipients list|
|DailyMed Link:||METAXALONE at DailyMed|